Skip to main content
Fig. 3 | Journal of Nanobiotechnology

Fig. 3

From: Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model

Fig. 3

Cytotoxic activity of free and encapsulated Dox at 72 h after a 4 h exposure to treatments. a Survival curves (or cell viability curves) of B16OVA cells exposed to increasing Dox concentrations; b IC50 concentration values. Data represent the average ± SD of three independent studies. Dox: doxorubicin; LPD: conventional Dox liposomes; LPF: targeted Dox liposomes; IC50: Dox concentration able to inhibit 50% of cell proliferation compared to control

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us